Canada markets close in 3 hours 41 minutes

Think Research Corporation (THNK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.8700+0.0700 (+8.75%)
As of 11:15AM EDT. Market open.
Full screen
Previous Close0.8000
Open0.8500
Bid0.8500 x N/A
Ask0.8700 x N/A
Day's Range0.8200 - 0.8700
52 Week Range0.4100 - 2.4800
Volume33,895
Avg. Volume50,040
Market Cap51.243M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.5890
Earnings DateAug 22, 2022 - Aug 26, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.91
  • CNW Group

    Think Research Announces Contract with St. George's University Hospitals NHS Foundation Trust to Deliver Nursing Care Plans

    Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a healthcare technology company focused on transforming healthcare through knowledge-based digital health software solutions, is pleased to announce it has signed a contract to provide Care Pathways nursing content to St. George's University Hospitals NHS Foundation Trust, a major teaching hospital in London, England and part of the largest public healthcare system in the world.

  • CNW Group

    Think Research to Participate in 3rd Annual TSX Venture Growth Capital Event On July 8 in Kelowna BC

    Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that at the invitation-only event Management will be speaking directly to small-cap investors regarding progress made over the past year.

  • CNW Group

    Think Research Signs 3-year SaaS Contract with Top U.S. Pharmacy Retailer

    Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that it has been contracted by a major U.S.-based pharmacy to deliver business intelligence and support solutions to more than 1700 pharmacies servicing 5.5 million patients throughout the United States. This contract is a direct result of the acquisition and subsequent integration of Pharmapod Ltd. ("Pharm